The Scaffold Protein PICK1 as a Target in Chronic Pain.

calcium permeable AMPAR drug development inflammatory pain maladaptive plasticity neuropathic pain therapeutic peptides

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
07 04 2022
Historique:
received: 08 03 2022
revised: 23 03 2022
accepted: 30 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Well-tolerated and effective drugs for treating chronic pain conditions are urgently needed. Most chronic pain patients are not effectively relieved from their pain and suffer from debilitating drug side effects. This has not only drastic negative consequences for the patients' quality of life, but also constitute an enormous burden on society. It is therefore of great interest to explore new potent targets for effective pain treatment with fewer side effects and without addiction liability. A critical component of chronic pain conditions is central sensitization, which involves the reorganization and strengthening of synaptic transmission within nociceptive pathways. Such changes are considered as maladaptive and depend on changes in the surface expression and signaling of AMPA-type glutamate receptors (AMPARs). The PDZ-domain scaffold protein PICK1 binds the AMPARs and has been suggested to play a key role in these maladaptive changes. In the present paper, we review the regulation of AMPARs by PICK1 and its relation to pain pathology. Moreover, we highlight other pain-relevant PICK1 interactions, and we evaluate various compounds that target PICK1 and have been successfully tested in pain models. Finally, we evaluate the potential on-target side effects of interfering with the action of PICK1 action in CNS and beyond. We conclude that PICK1 constitutes a valid drug target for the treatment of inflammatory and neuropathic pain conditions without the side effects and abuse liability associated with current pain medication.

Identifiants

pubmed: 35455935
pii: cells11081255
doi: 10.3390/cells11081255
pmc: PMC9031029
pii:
doi:

Substances chimiques

Carrier Proteins 0
Nuclear Proteins 0
PICk1 protein, human 0
Receptors, AMPA 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pain. 2007 Sep;131(1-2):3.e1-4
pubmed: 17574758
Mol Biol Cell. 2015 Dec 15;26(25):4552-61
pubmed: 26466675
Nat Genet. 2022 Apr;54(4):412-436
pubmed: 35379992
J Comp Neurol. 2009 Nov 20;517(3):313-32
pubmed: 19757495
Sci Rep. 2013 Oct 08;3:2842
pubmed: 24100262
Neurosci Bull. 2012 Apr;28(2):111-20
pubmed: 22466122
Brain. 2019 May 1;142(5):1215-1226
pubmed: 30887021
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):413-8
pubmed: 20018661
Trends Pharmacol Sci. 2006 Nov;27(11):574-9
pubmed: 17011050
Neuropharmacology. 1999 May;38(5):635-44
pubmed: 10340301
J Pain. 2009 Sep;10(9):895-926
pubmed: 19712899
Protein Sci. 2018 Mar;27(3):672-680
pubmed: 29280296
Neuron. 2000 Nov;28(2):499-510
pubmed: 11144359
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21784-9
pubmed: 21106762
Addict Biol. 2021 Sep;26(5):e13051
pubmed: 34110073
J Neurosci. 2011 Feb 9;31(6):2188-96
pubmed: 21307255
Neural Plast. 2020 Dec 31;2020:8861994
pubmed: 33488694
Eur J Pain. 2006 May;10(4):287-333
pubmed: 16095934
Structure. 2015 Jul 7;23(7):1258-1270
pubmed: 26073603
Pain. 2018 Jul;159(7):1325-1345
pubmed: 29561359
Neuron. 2000 Dec;28(3):873-86
pubmed: 11163273
J Proteome Res. 2019 Feb 1;18(2):623-632
pubmed: 30450911
Neuron. 2006 Mar 16;49(6):845-60
pubmed: 16543133
Neurosci Res. 2003 Sep;47(1):3-15
pubmed: 12941441
Am J Hum Genet. 2013 Dec 5;93(6):1072-86
pubmed: 24290377
Cell Rep. 2018 May 15;23(7):2056-2069
pubmed: 29768204
Sci Rep. 2018 Sep 7;8(1):13438
pubmed: 30194389
Brain Behav. 2021 Nov;11(11):e2380
pubmed: 34582111
J Neurosci. 1999 Aug 15;19(16):6930-41
pubmed: 10436050
J Biol Chem. 2014 Sep 5;289(36):25327-40
pubmed: 25023278
Front Neurol. 2019 Jan 09;9:1169
pubmed: 30687223
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11999-2004
pubmed: 20547835
J Exp Clin Cancer Res. 2020 Apr 26;39(1):71
pubmed: 32336285
J Neurosci. 2009 Mar 11;29(10):3206-19
pubmed: 19279258
Cochrane Database Syst Rev. 2015 Jul 06;(7):CD008242
pubmed: 26146793
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
J Clin Invest. 2022 Mar 1;132(5):
pubmed: 35077398
Channels (Austin). 2021 Dec;15(1):284-297
pubmed: 33565904
Med Oncol. 2021 Mar 4;38(4):34
pubmed: 33660148
Neuron. 1998 Jul;21(1):87-97
pubmed: 9697854
Nat Neurosci. 2021 Nov;24(11):1601-1613
pubmed: 34663957
Science. 2003 Jun 13;300(5626):1751-5
pubmed: 12805550
Cell Death Differ. 2009 Dec;16(12):1665-80
pubmed: 19644508
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Neuroscience. 1996 Sep;74(1):7-12
pubmed: 8843072
Pain. 2010 Oct;151(1):226-234
pubmed: 20696523
Neuron. 2002 Mar 28;34(1):53-67
pubmed: 11931741
Biochem Soc Trans. 2006 Nov;34(Pt 5):931-5
pubmed: 17052230
J Clin Invest. 2009 Apr;119(4):802-12
pubmed: 19258705
J Biol Chem. 2001 Oct 26;276(43):40025-32
pubmed: 11498531
J Neurosci. 2010 May 5;30(18):6360-6
pubmed: 20445062
eNeuro. 2018 Jun 11;5(3):
pubmed: 29911172
Neuron. 1999 Jan;22(1):179-87
pubmed: 10027300
J Neurosci. 2010 Dec 8;30(49):16437-52
pubmed: 21147983
J Neurosci. 2012 Aug 22;32(34):11618-30
pubmed: 22915106
Pain. 2019 Mar;160(3):712-723
pubmed: 30699097
Exp Neurol. 2017 Jul;293:144-158
pubmed: 28412220
J Biol Chem. 2014 Jul 4;289(27):19218-30
pubmed: 24831007
Mol Pain. 2011 Feb 03;7:11
pubmed: 21291534
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11725-30
pubmed: 11573007
Science. 2007 Jul 27;317(5837):530-3
pubmed: 17656725
J Biol Chem. 1997 Dec 19;272(51):32019-24
pubmed: 9405395
J Biol Chem. 1998 Jul 31;273(31):19518-24
pubmed: 9677374
Cell Res. 2012 Oct;22(10):1467-78
pubmed: 22710801
Br J Cancer. 2017 Aug 22;117(5):685-694
pubmed: 28697177
Neuroreport. 2004 Aug 26;15(12):1965-7
pubmed: 15305146
J Neurosci. 2013 Aug 28;33(35):14160-9
pubmed: 23986250
J Neurosci. 2001 Aug 1;21(15):5417-28
pubmed: 11466413
Neurochem Res. 2011 Jan;36(1):170-6
pubmed: 20953906
EMBO Mol Med. 2020 Jun 8;12(6):e11248
pubmed: 32352640
Nat Genet. 2021 Mar;53(3):392-402
pubmed: 33589840
Neuron. 2008 Mar 27;57(6):872-82
pubmed: 18367088
Neurosignals. 2006-2007;15(4):190-201
pubmed: 17215589
J Neurosci. 2004 Jun 9;24(23):5381-90
pubmed: 15190111
Nat Neurosci. 2008 Aug;11(8):940-8
pubmed: 18641645
Neuropharmacology. 2020 Mar 1;164:107901
pubmed: 31805281
Biol Psychiatry. 2008 May 15;63(10):997-1000
pubmed: 18191108
PLoS Biol. 2013;11(4):e1001542
pubmed: 23630454
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Trends Neurosci. 2014 Jun;37(6):343-55
pubmed: 24833289
Angew Chem Int Ed Engl. 2009;48(51):9685-9
pubmed: 19937879
Pain. 2018 Apr;159(4):749-763
pubmed: 29300278
Front Cell Neurosci. 2018 Apr 20;12:107
pubmed: 29731710
Nat Neurosci. 2006 May;9(5):636-41
pubmed: 16582902
J Neurosci. 2000 Oct 1;20(19):7252-7
pubmed: 11007882
Mol Psychiatry. 2006 Feb;11(2):150-7
pubmed: 16314870
Asian J Androl. 2010 Jul;12(4):556-60
pubmed: 20562896
J Neurosci. 2000 Oct 1;20(19):7258-67
pubmed: 11007883
Pain. 2021 Aug 1;162(8):2273-2286
pubmed: 33900711
Anal Cell Pathol (Amst). 2019 Dec 01;2019:5310684
pubmed: 31886120
Nat Neurosci. 2005 Jun;8(6):768-75
pubmed: 15895086
PLoS Biol. 2013;11(4):e1001541
pubmed: 23630453
Eur J Neurosci. 2012 Jun;35(12):1908-16
pubmed: 22708602
J Neurophysiol. 2003 Feb;89(2):716-27
pubmed: 12574449
Cell Rep. 2020 Oct 27;33(4):108312
pubmed: 33113376
Org Biomol Chem. 2010 Oct 7;8(19):4281-8
pubmed: 20668766
Mol Cell Neurosci. 2003 Sep;24(1):10-22
pubmed: 14550765
Neurosci Res. 2007 Jun;58(2):145-8
pubmed: 17367885
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
Sci Rep. 2021 Jan 27;11(1):2329
pubmed: 33504897
J Biol Chem. 2009 May 22;284(21):14230-5
pubmed: 19321442
Neuron. 2005 Mar 24;45(6):903-15
pubmed: 15797551
Eur J Neurosci. 2014 Apr;39(7):1225-33
pubmed: 24713001
Neuron. 2004 Nov 18;44(4):637-50
pubmed: 15541312
Lancet. 2021 May 29;397(10289):2082-2097
pubmed: 34062143
Cancer Sci. 2010 Jun;101(6):1536-42
pubmed: 20384629
J Neurosci. 2008 Oct 22;28(43):11061-70
pubmed: 18945913
J Physiol. 2021 May;599(10):2655-2671
pubmed: 33533533
Membranes (Basel). 2015 Oct 16;5(4):597-615
pubmed: 26501328
Neuron. 2005 Aug 4;47(3):407-21
pubmed: 16055064
J Cell Biol. 1995 Feb;128(3):263-71
pubmed: 7844141
Neuron. 2018 Oct 24;100(2):314-329
pubmed: 30359599
Nat Neurosci. 1999 Nov;2(11):972-7
pubmed: 10526335
Front Cell Neurosci. 2021 Dec 15;15:750902
pubmed: 34975407
Sci Rep. 2017 May 15;7(1):1889
pubmed: 28507309

Auteurs

Andreas Toft Sørensen (AT)

Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Joscha Rombach (J)

Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Ulrik Gether (U)

Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Kenneth Lindegaard Madsen (KL)

Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH